SCHEMBL29570686

SCHEMBL29570686

COC(=O)c1c(C)ccc(Br)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
TSHR P16473 3/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 2/20 0.41
GAA P10253 1/20 0.41
CYP3A4 P08684 2/20 0.40
ACHE P22303 1/20 0.40
PTGS2 P35354 1/20 0.39
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 2/20 0.39
GLA P06280 1/20 0.39
NR4A2 P43354 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27474347 0.86 PTGS2 (0.42) CA12CA1CA2CA7CA9
SCHEMBL5784489 0.84 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL30337010 0.84 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL11137262 0.81 CA12 (0.44) CA12CA1CA2CA7CA9
SCHEMBL17376170 0.81 ABL1 (0.44) CA12CA1CA2CA7CA9
SCHEMBL21416073 0.81 ALDH1A1 (0.42) CA12CA1CA2CA7CA9
SCHEMBL434350 0.80 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL29570348 0.79 ALDH1A1 (0.40) CYP3A4ACHEPTGS2KDM4EHSD17B10
SCHEMBL19792296 0.79 CA12 (0.41) CA12CA1CA2CA7CA9
SCHEMBL30004188 0.79 MAPT (0.43) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229056-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2023-08-23 EP disclosed
WO-2022086828-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2022-04-28 WO disclosed